Asia Series Insights brings the direct views of
Europe and Asia’s most revered thinkers to
strategic decision-makers around the world.

Loading ...

Novartis in India: A Patent War

Alan Rosling / Former Executive Director, Tata Group


Alan Rosling reflects on the Indian Supreme Court's 2013 ruling where Novartis lost the right to a patent for the cancer drug Gleevec.